We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The overall response rates to washed microbiota ...

A newly approved option for pediatric patients with functional constipation significantly increased the frequency of bowel movements and improved other burdensome symptoms as well, according to a ...

(Reuters Health) – Child-rearing practices and attitudes could be contributing factors when kids have chronic constipation issues, according to a new study from the Netherlands. "Stool-withholding and ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Linzess, the first therapy for pediatric functional constipation in patients aged 6 to 17 ...

The US Food and Drug Administration (FDA) has expanded the indication for linaclotide (Linzess) to children as young as age 6 years with functional constipation, making it the first approved treatment ...

– Data demonstrates that linaclotide reduces the need for rescue medications in this patient population – – Additional presentations further characterize the efficacy and safety profiles of ...